3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Neoplasm Metastasis
10
Carcinoma, Non-Small-Cell Lung
10
Breast Neoplasms
9
Lung Neoplasms
5
Prostatic Neoplasms
4
Pancreatic Neoplasms
4
Neoplasms
4
Leukemia, Myeloid, Acute
4
Colorectal Neoplasms
4
Triple Negative Breast Neoplasms
3
Rectal Neoplasms
3
Melanoma
3
Leukemia
3
Glioblastoma
3
Cholangiocarcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Recurrence
2
Gliosarcoma
2
Glioma
2
Congenital Abnormalities
2
Colonic Neoplasms
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Stomatitis
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleural Effusion, Malignant
1
Pain
1
Interventions
Injections
2
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
2
alovudine
1
Nitroglycerin
1
Magnetic Resonance Spectroscopy
1
Exercise
1
Drug Therapy
1
Bacterial Load
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Hypoxia
×
Drug Therapy
×
Clear all
NCT03513042
2022-12-06
ERM-PT-HNSCC
Leiden University Medical Center
Terminated
12 enrolled